T cell protein tyrosine phosphatase prevents STAT1 induction of claudin-2 expression in intestinal epithelial cells
Moorthy Krishnan1, Declan F McCole1
1Division of Biomedical Sciences, University of California, Riverside, California.
Abstract:
T cell protein tyrosine phosphatase (TCPTP) dephosphorylates a number of substrates, including JAK-STAT (signal transducer and activator of transcription) signaling proteins, which are activated by interferon (IFN)-γ, a major proinflammatory cytokine involved in conditions such as inflammatory bowel disease. A critical function of the intestinal epithelium is formation of a selective barrier to luminal contents. The structural units of the epithelium that regulate barrier function are the tight junctions (TJs), and the protein composition of the TJ determines the tightness of the barrier. Claudin-2 is a TJ protein that increases permeability to cations and reduces transepithelial electrical resistance (TER). We previously showed that transient knockdown (KD) of TCPTP permits increased expression of claudin-2 by IFN-γ. Here, we demonstrate that the decreased TER in TCPTP-deficient epithelial cells is alleviated by STAT1 KD. Moreover, increased claudin-2 in TCPTP-deficient cells requires enhanced STAT1 activation and STAT1 binding to the CLDN2 promoter. We also show that mutation of this STAT-binding site prevents elevated CLDN2 promoter activity in TCPTP-deficient epithelial cells. In summary, we demonstrate that TCPTP protects the intestinal epithelial barrier by restricting STAT-induced claudin-2 expression. This is a potential mechanism by which loss-of-function mutations in the gene encoding TCPTP may contribute to barrier defects in chronic intestinal inflammatory disease.
Insights
T cell protein tyrosine phosphatase (TCPTP) protects the intestinal barrier by limiting claudin-2 expression via STAT1 signaling. Loss of TCPTP function may worsen inflammatory bowel disease by disrupting this barrier.
Area of Science:
- Molecular biology
- Cell biology
- Immunology
Background:
- The intestinal epithelium forms a selective barrier regulated by tight junctions (TJs).
- Claudin-2 is a TJ protein that increases intestinal permeability and reduces transepithelial electrical resistance (TER).
- Interferon-gamma (IFN-γ), a proinflammatory cytokine, activates JAK-STAT signaling and can increase claudin-2 expression.
Purpose of the Study:
- To investigate the role of T cell protein tyrosine phosphatase (TCPTP) in regulating intestinal epithelial barrier function.
- To elucidate the mechanism by which TCPTP deficiency affects claudin-2 expression and barrier integrity.
- To determine the involvement of STAT1 signaling in TCPTP-mediated regulation of claudin-2.
Main Methods:
- Utilized TCPTP-deficient epithelial cells and transient knockdown (KD) of TCPTP and STAT1.
- Measured transepithelial electrical resistance (TER) to assess barrier function.
- Analyzed claudin-2 expression, STAT1 activation, and STAT1 binding to the CLDN2 promoter.
- Employed site-directed mutagenesis of the STAT-binding site in the CLDN2 promoter.
Main Results:
- Decreased TER in TCPTP-deficient cells was alleviated by STAT1 KD.
- Increased claudin-2 expression in TCPTP-deficient cells required enhanced STAT1 activation and binding to the CLDN2 promoter.
- Mutation of the STAT-binding site prevented elevated CLDN2 promoter activity in TCPTP-deficient cells.
Conclusions:
- TCPTP protects the intestinal epithelial barrier by restricting STAT-induced claudin-2 expression.
- Loss-of-function mutations in TCPTP may contribute to intestinal barrier defects in chronic inflammatory diseases.
- TCPTP acts as a negative regulator of STAT1-mediated claudin-2 expression in the intestinal epithelium.
Related Concept Videos
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Tight Junctions
The JAK-STAT Signaling Pathway
Renewal of Intestinal Stem Cells
Abnormal Proliferation


